Zyesami
Showing 1 - 5 of 5
SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)
Withdrawn
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
Feb 2, 2023
SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or
Terminated
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
-
Fullerton, California
- +12 more
Feb 2, 2023
Critical COVID-19 With Respiratory Failure Trial in United States (ZYESAMI (aviptadil acetate))
No longer available
- Critical COVID-19 With Respiratory Failure
- ZYESAMI (aviptadil acetate)
-
Gilbert, Arizona
- +24 more
Jul 19, 2022
Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Corona Virus Infection Trial in United
Completed
- Critical COVID-19 With Respiratory Failure
- +3 more
- Aviptadil by intravenous infusion + standard of care
- Normal Saline Infusion + standard of care
-
Fullerton, California
- +9 more
Sep 5, 2021
